Previous 10 | Next 10 |
2023-05-09 08:19:46 ET Summary I present additional information about my methodology for finding the best stocks. Some of the technical tools I use to make final decisions to buy or sell. The leadership of certain stocks and sectors changes occasionally, and we can take this i...
2023-05-09 07:19:44 ET Assertio Therapeutics press release ( NASDAQ: ASRT ): Q1 Non-GAAP EPS of $0.29 beats by $0.07 . Revenue of $42.47M (+16.2% Y/Y) beats by $4.83M . Raises Full Year Outlook to Net Product Sales of $157 to $167 Million, Adjusted EBITDA $90...
Net Product Sales Increase 18% Year-Over -Year Raises Full Year Outlook to Net Product Sales of $157 to $167 Million, Adjusted EBITDA $90 to $98 Million To Acquire Spectrum Pharmaceuticals in All Stock and CVR Transaction, Expected to be Significantly Accretive to Adjusted E...
2023-05-08 12:31:43 ET Assertio Therapeutics ( NASDAQ: ASRT ) is scheduled to announce Q1 earnings results on Tuesday, May 9th, before market open. The consensus EPS Estimate is $0.22 (-42.1% Y/Y) and the consensus Revenue Estimate is $37.64M (+3.0% Y/Y). Over the last...
2023-05-08 11:26:20 ET Major earning expected before the bell on Tuesday include: Cronos Group ( CRON ) Duke Energy ( DUK ) Nikola ( NKLA ) Novavax ( NVAX ) Plug Power ( PLUG ) For further details see: Notable earnings before Tuesday's open
2023-05-05 13:09:12 ET The simple definition of penny stocks includes stocks under $5. Some traders might say they are limited to only the Over-The-Counter or “OTC exchange.” But in reality, plenty of cheap stocks are trading on larger exchanges. In the stock market today,...
2023-05-04 13:38:47 ET Summary A shocking M&A move tanked the stock, but it is recovering. Some are skeptical about the newly-acquired product, but it is better than a blockbuster rival. Through it all, the company is still a deep value play. Assertio ( ASRT ) is...
2023-05-04 03:08:32 ET Summary My journey on the road to finding the best portfolio. My early attempts to find the best stocks in which to invest. My success in finding the best methods. I feel it is about time to publish my latest stock recommendations as I have, I ...
2023-05-02 10:18:49 ET Summary Assertio Holdings stock has fallen 8.15% since my updated bullish thesis in March 2023, while the S&P 500 Index has gained 4.95% over the same period. The SPPI deal is expected to give Assertio access to Rolvedon and be accretive to adjusted EPS ...
NEW YORK, NY / ACCESSWIRE / April 30, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Hoth Therapeutics, Inc. (NASDAQ:HOTH...
News, Short Squeeze, Breakout and More Instantly...
Assertio Therapeutics Inc. Company Name:
ASRT Stock Symbol:
NASDAQ Market:
Assertio Therapeutics Inc. Website:
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ASRT on July 3, 2024 06:04AM ET. ASRT was trading at $1.15 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief...
LAKE FOREST, Ill., May 29, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that its Board of...